$42.80
Price
$1.9B
Market Cap
—
P/E Ratio
-15.3
Forward P/E
$-1.86
EPS (TTM)
—
Dividend Yield
$216M
Cash
$9M
Total Debt
45M
Shares Out
$13.26
$48.45
52-Week Range
Institutional Ownership of SIONNA THERAPEUTICS INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for SIONNA THERAPEUTICS INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2025-Q3 | |||||
| BUY | +84.1% | 31.3K | $919298 | $21.19 | |
| 2025-Q2 | |||||
| BUY | +8.2% | 3.2M | $55M | $12.90 | |
| BUY | NEW | 17.0K | $294516 | $12.90 | |
| 2025-Q1 | |||||
| BUY | NEW | 3.0M | $31M | $15.65 | |
Insider Trading for SIONNA THERAPEUTICS INC
6 Months Insider Sentiment
Buy $0
Sell $3.6M
0
Buys
9
Sells
-3.6M
Net
0
Grants
Largest
$1.5M
Thompson
$1.5M
LLC
$415K
Fitzpatrick
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 24, 2025 | Peter A. Thompson | Director | SELL | 33.4K | $44.55 | $1.5M |
| Dec 24, 2025 | ORBIMED ADVISORS LLC | Director | SELL | 33.4K | $44.55 | $1.5M |
| Dec 19, 2025 | ORBIMED ADVISORS LLC | Director | SELL | 875 | $44.49 | $39K |
| Dec 19, 2025 | Peter A. Thompson | Director | SELL | 875 | $44.49 | $39K |
| Dec 18, 2025 | ORBIMED ADVISORS LLC | Director | SELL | 100 | $44.49 | $4K |
| Dec 18, 2025 | Peter A. Thompson | Director | SELL | 100 | $44.49 | $4K |
| Dec 17, 2025 | ORBIMED ADVISORS LLC | Director | SELL | 900 | $44.50 | $40K |
| Dec 17, 2025 | Peter A. Thompson | Director | SELL | 900 | $44.50 | $40K |
| Dec 05, 2025 | Jennifer Fitzpatrick | Chief Legal Officer | EXERCISE | 10.2K | $6.11 | $63K |
| Dec 05, 2025 | Jennifer Fitzpatrick | Chief Legal Officer | SELL | 10.2K | $40.52 | $415K |